A melanoma vaccine that works? Evidence for a phase III national trial.
Reintgen
D S
DS
Shivers
S C
SC
D019496:Cancer Vaccines / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D003165:Complement System Proteins / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D006801:Humans; D008545:Melanoma / Q000276:immunology* / Q000628:therapy*; D012878:Skin Neoplasms / Q000276:immunology* / Q000628:therapy*; D016019:Survival Analysis; D016896:Treatment Outcome
D019496:Cancer Vaccines; D003165:Complement System Proteins